936942-17-5

Basic information

• Product Name: 2-[2-(2-2-[4-(3-bromo-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethoxyethoxy)-ethoxy]-ethanol
• Synonyms: 2-[2-(2-2-[4-(3-bromo-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethoxyethoxy)-ethoxy]-ethanol
• CAS NO: 936942-17-5
• Molecular Weight: 537.367
• Mol File: 936942-17-5.mol

Chemical Properties

• CAS DataBase Reference: 2-[2-(2-2-[4-(3-bromo-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethoxyethoxy)-ethoxy]-ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(2-2-[4-(3-bromo-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethoxyethoxy)-ethoxy]-ethanol(936942-17-5)
• EPA Substance Registry System: 2-[2-(2-2-[4-(3-bromo-phenylamino)-6-nitro-quinazolin-7-yloxy]-ethoxyethoxy)-ethoxy]-ethanol(936942-17-5)

Safety Data

• Hazardous Substances Data: 936942-17-5(Hazardous Substances Data)

Upstream product

• 134179-40-1 tetraethyleneglycol mono(tert-butyldimethylsilyl)ether 
• 174709-17-2 4-[(3-bromophenyl)amino]-7-fluoro-6-nitro-quinazoline 

Relevant articles and documents

Modified PEG-anilinoquinazoline derivatives as potential EGFR PET agents

Inhibition of epidermal growth factor receptor tyrosine kinase (EGFR-TK) has emerged as a major approach for cancer-targeted therapy. Consequently, there has been a great interest in the use of labeled EGFR-TK inhibitors as positron emission tomography (P